Chaime Orlev - 27 Aug 2026 Form 4 Insider Report for KAMADA LTD (KMDA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
23 Sep 2026, 15:53:33 UTC
Prior SEC filing
09 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Chaime Orlev

Key filing fact

Chaime Orlev filed Form 4 for KAMADA LTD (KMDA) on 23 Sep 2026.

Key facts

  • This page summarizes Chaime Orlev's Form 4 filing for KAMADA LTD (KMDA).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 23 Sep 2026, 15:53.

Change

  • Previous filing in this sequence was filed on 09 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001345636 Primary reporting owner

ORLEV CHAIME

Relationship
Chief Financial Officer
Address
2 HOLTZMAN ST., REHOVOT, ISRAEL
Signature
/s/ Chaime Orlev
Signature date
23 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KMDA transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares
+22,500
Change %
Price
$0.000000*
Shares after
22,500
Date
27 Aug 2026
Ownership
Held by trustee
Underlying class
Ordinary Shares
Underlying amount
22,500
Exercise price
$5.98
Footnotes
F1, F2, F3, F4
KMDA transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares
+90,000
Change %
Price
$0.000000*
Shares after
90,000
Date
27 Aug 2026
Ownership
Held by trustee
Underlying class
Ordinary Shares
Underlying amount
90,000
Exercise price
$6.02
Footnotes
F1, F2, F3, F5
KMDA transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares
+90,000
Change %
Price
$0.000000*
Shares after
90,000
Date
27 Aug 2026
Ownership
Held by trustee
Underlying class
Ordinary Shares
Underlying amount
90,000
Exercise price
$7.44
Footnotes
F1, F2, F3, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

Footnote F2

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Footnote F3

Held by trustee under the Company's 2011 Share Award Plan.

Footnote F4

This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Footnote F5

This option was previously reported as covering 90,000 ordinary shares at an exercise price of $6.19. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Footnote F6

This option was previously reported as covering 90,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .